Latest news
Enterprise value to EBIT forward of Lisata Therapeutics, Inc. – NASDAQ:LSTA - TradingViewTradingView · Sat, 08 Aug 2026 21:19:15 GMTLisata Therapeutics (8NE) Q4 2023 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 08 Aug 2026 09:22:40 GMTLisata Therapeutics Inc. (NASDAQ: LSTA) Share Price, LSTA Stock News, LSTA Share Price & Updates - KalkineKalkine · Fri, 07 Aug 2026 20:00:00 GMTLISATA THERAPEUTICS, INC. 2026: Revenue $0 EPS ($0.32) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMTLisata Therapeutics Cuts 72% of Workforce and Sues Kuva Labs Following Failed Merger - geneonline.comgeneonline.com · Wed, 05 Aug 2026 02:07:22 GMTLisata axes 72% of workforce following failed merger with Kuva - BioSpaceBioSpace · Tue, 04 Aug 2026 18:43:39 GMTLisata Therapeutics, Inc. Continues to Evaluate Strategic Alternatives to Enhance Stockholder Value - marketscreener.commarketscreener.com · Tue, 04 Aug 2026 16:35:26 GMTLisata Therapeutics (LSTA) Pursues Legal Action After Merger Ter - GuruFocusGuruFocus · Tue, 04 Aug 2026 15:59:40 GMT